News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
PCI Recognized In Clinical Leader Article about How Academic Medical Centers Can Capture Greater Value In The Cell & Gene Therapy Industry
The Penn Center of Innovation was recognized in an article in Clinical Leader about how academic medical centers can leverage their unique advantages to develop and deliver cell and gene therapies.
National Academy of Medicine Elects Five Penn Experts
Five Penn experts have been elected to the National Academy of Medicine (NAM), one of the nation’s highest honors in the fields of health and medicine.
Opus Genetics Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in Patients with Rare Inherited Retinal Disease LCA5
Penn spinout Opus Genetics announced that the first patient has been dosed in its Phase 1/2, first-in-human clinical trial of OPGx-LCA5.
Penn biomedical scientists move into new uCity complex with 115,000 square feet of lab space
A group of Penn scientists and engineers is moving into 115,000 square feet of new lab space in the 13-story One uCity Square building in West Philadelphia.
Team members of I Corps Team and Penn President’s Prize Winner Sonura are Named Philadelphia Business Journal’s “Inno Under 25”
The group was named as 2023’s Inno Under 25 honorees by the Philadelphia Business Journal.
PCI and Penn Medicine Represent at PHILLY BUILDS BIO+: 2ND ANNUAL SYMPOSIUM FOR LIFE SCIENCE INNOVATION AND DEVELOPMENT
Jon Epstein was keynote speaker and Ben Dibling served on a panel discussing science and technology in the context of accelerating innovation.
Penn Spinout Heirloom Technologies and Microsoft Sign One of the Largest Permanent CO2 Removal Deals To-Date
Microsoft signed a long term contract to purchase up to 315,000 metric tons of CO2 removal over a multi-year period from Penn spinout Heirloom Carbon Technologies.
BlueWhale Bio, a New Cell Therapy Production Company, Emerges from Stealth Mode
In September 2023, Penn spinout BlueWhale Bio surfaced with a mission to overhaul cell therapy production.
Exyn Technologies Closes on Series B Funding
Exyn has a mission to deliver world-class autonomous robots to data-hungry industries that include mining, logistics and construction.
Katalin Karikó and Drew Weissman Named Co-Recipients of the 2023 Nobel Prize for Medicine
Penn’s Katalin Karikó, PhD, and Drew Weissman, MD, PhD, have been named winners of the 2023 Nobel Prize in Physiology or Medicine.